Back
FibroGen Vs. Cue Biopharma Industry Stock Comparison
Buy
54
FGEN
FibroGen
Last Price:
0.38
Seasonality Move:
50.95%
Sell
21
CUE
Cue Biopharma
Last Price:
1.10
Seasonality Move:
14.02%
Buy
54
FibroGen (FGEN)
is a Buy
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $0.39. The Score for FGEN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- FGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.06. The Score for CUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FGEN Stock Price Chart
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing selling pressure, which indicates risk of future bearish movement.
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 58.01 | Buy |
| Chaikin Money Flow: | -390532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.31 - 0.37) | Buy |
| Bollinger Bands (100): | (0.23 - 0.77) | Sell |
CUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 39.33 | Sell |
| Chaikin Money Flow: | -607350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.75) | Sell |
| Bollinger Bands (100): | (0.57 - 1.35) | Buy |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.36 | Buy |
| 20-day SMA: | 0.34 | Buy |
| 50-day SMA: | 0.36 | Buy |
| 200-day SMA: | 1.01 | Sell |
| 8-day EMA: | 0.37 | Buy |
| 20-day EMA: | 0.35 | Buy |
| 50-day EMA: | 0.38 | Buy |
| 200-day EMA: | 1.21 | Sell |
CUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.14 | Sell |
| 20-day SMA: | 1.45 | Sell |
| 50-day SMA: | 1.19 | Sell |
| 200-day SMA: | 1.36 | Sell |
| 8-day EMA: | 1.16 | Sell |
| 20-day EMA: | 1.31 | Sell |
| 50-day EMA: | 1.24 | Sell |
| 200-day EMA: | 1.45 | Sell |
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
FibroGen Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cue Biopharma Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||